Back

Prognostic value of NT-ProBNP/BNP ratio in patients with heart failure and reduced ejection fraction using sacubitril-valsartan: systematic review and post hoc analysis of PARADIGM-HF Trial

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Diagnostic Methods Biomarkers HFA Premium Access Heart Failure 2018

26 More presentations in this session

Presentation thumbnail
Diastolic dysfunction as a prognosticator in patients with heart failure with preserved ejection fraction
Professor G. Cho (Seongnam, KR)
Abstract Slides
Presentation thumbnail
Relationship between aldosterone level and comorbidities in chronic heart failure with preserved ejection fraction
Associate Professor A. Shevelyok (Donetsk, UA)
Abstract Slides
Presentation thumbnail
Predictive models of mortality and readmission in patients with chronic heart failure and preserved ejection fraction
Doctor A. Mendez Fernandez (Barcelona, ES)
Abstract
Presentation thumbnail
Cardiovascular biomarkers predict post-discharge rehospitalization risk and mortality among swedish heart failure patients
Doctor J. Molvin (Malmoe, SE)
Abstract
Presentation thumbnail
Exhaled acetone in the differential diagnostics of heart failure
Assistant Professor A. Bykova (Moscow, RU)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Diagnostic Methods

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources